Effects of β-1.3/1.6 glucan on cytokines production by leukocytes in vitro

• Authors: Jurgina Sakalauskiene , Laimis Akramas , Alvydas Gleiznys , Ricardas Kubilius , Astra Vitkauskiene , Algimantas Surna , Jonas Junevicius
• Languages of publication: EN

Abstracts

EN

Keywords

EN

Periodontal disease; β-1,3/1,6 glucan; Interleukin-4; Interleukin-5; Predictors; Markers; Microalbuminuria

• Publisher: De Gruyter Open
• Journal: Open Medicine
• Year: 2012
• Volume: 7
• Issue: 6
• Pages: 800-807

Dates

published

1 - 12 - 2012

online

11 - 10 - 2012

Contributors

author

Jurgina Sakalauskiene

• Department of Dental and Maxillofacial Orthopedics, Medical Academy, Lithuanian University of Health Sciences, LT-50106, Kaunas, Lithuania

author

Laimis Akramas

• Department of Microbiology, Medical Academy, Lithuanian University of Health Sciences, LT-50106, Kaunas, Lithuania

author

Alvydas Gleiznys

• Department of Dental and Maxillofacial Orthopedics, Medical Academy, Lithuanian University of Health Sciences, LT-50106, Kaunas, Lithuania

author

Ricardas Kubilius

• Department of Maxillofacial Surgery and Surgical Stomatology, Medical Academy, Lithuanian University of Health Sciences, LT-50106, Kaunas, Lithuania

author

Astra Vitkauskiene

• Departament of Laboratory Medicine, Lithuanian University of Health Sciences, LT-50106, Kaunas, Lithuania

author

Algimantas Surna

• Department of Dental and Maxillofacial Orthopedics, Medical Academy, Lithuanian University of Health Sciences, LT-50106, Kaunas, Lithuania

author

Jonas Junevicius

• Department of Dental and Maxillofacial Orthopedics, Medical Academy, Lithuanian University of Health Sciences, LT-50106, Kaunas, Lithuania

References

• [1] Martin JA, Page RC, Loeb CF, Levi JPA. Tooth loss in 776 treated periodontal patients. J Periodontol 2010;81:244–250 http://dx.doi.org/10.1902/jop.2009.090184
• [2] Nussbaum G, Shapira L. How has neutrophil research improved our understanding of periodontal pathogenesis? J Clin Periodontol 2011;38:49–59 http://dx.doi.org/10.1111/j.1600-051X.2010.01678.x[WoS][Crossref]
• [3] Kinane DF, Preshaw PM, Loos BG. Host-response: understanding the cellular and molecular mechanisms of host-microbial interactions-Consensus of the Seventh European Workshop on Periodontology. J Clin Periodontol 2011;38:44–48 http://dx.doi.org/10.1111/j.1600-051X.2010.01682.x[Crossref][WoS]
• [4] Deo V, Bhongade ML. Pathogenesis of periodontitis: role of cytokines in host response. Dent Today. 2010:29;60–62, 64–6, quiz 68–69
• [5] Kobie JJ, Shah PR, Yang L, Rebhahn JA, Fowell DJ, Mosmann TR. T regulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 T cells by converting 5’-adenosine monophosphate to adenosine. J Immunol. 2006;15;177:6780–6786
• [6] Prabhu A, Michalowicz BS, Mathur A. Detection of local and systemic cytokines in adult periodontitis. J. Periodont.1996; 67:515–522 http://dx.doi.org/10.1902/jop.1996.67.5.515[Crossref]
• [7] Matsuki Y, Yamamoto T, Hara K. 1992. Detection of inflammatory cytokine messenger-RNA (mRNA)-expressing cells in human inflamed gingiva by combined in situ hybridization and immunohistochemistry. Immunology 1992;76: 42–47 [PubMed]
• [8] O’Brien-Simpson NM, Pathirana RD, Paolini RA, Chen YY, Veith PD, Tam V, Ally N, Pike RN, Reynolds EC. An immune response directed to proteinase and adhesin functional epitopes protects against Porphyromonas gingivalis-induced periodontal bone loss. J Immunol 2005; 175:3980–3989
• [9] Stashenko P, Goncalves RB, Lipkin B, Ficarelli A, Sasaki H, Campos-Neto A. Th1 immune response promotes severe bone resorption caused by Porphyromonas gingivalis. Am. J. Pathol. 2007; 170:203–213 http://dx.doi.org/10.2353/ajpath.2007.060597[WoS]
• [10] Novak M, Vetvicka V. Glucans as biological response modifiers. Endocrine, metabolic and immune disorders-drugs targets. 2009;9:67–75
• [11] Vetvicka V. Glucan-immunostimulant, adjuvant, potential drug. World J Clin Oncol 2011;10:115–9. http://dx.doi.org/10.5306/wjco.v2.i2.115[Crossref]
• [12] Russell A L. Epidemiology of periodontal disease. Int Dent J. 1967;17:282–296 [PubMed]
• [13] Timm M, Baehr R, Hildebrand A. Lysozyme release assay - a method for proof of activation of human neutrophil granulocytes and monocytes. Allerg and Immunol. 1984;30: 175–182
• [14] Johannessen L, Lovik M, Lydersen S, Nilsen A M. Combined cell wall polysaccharide, mycotoxin and bacterial lipopolysaccharide exposure and inflammatory cytokine responses. APMIS 2009;117:507–517 http://dx.doi.org/10.1111/j.1600-0463.2009.02462.x[Crossref][WoS]
• [15] Sonck E, Stuyven E, Goddeeris B, Cox E. The effect of beta-glucans on porcine leukocytes. Vet Immunol Immunopathol. 2010;135(3–4):199–207 http://dx.doi.org/10.1016/j.vetimm.2009.11.014[WoS][Crossref]
• [16] Stopinsek S, Ihan A, Wraber B, Tercelj M, Salobir B, Rylander R, Simcic S. Fungal cell wall agents suppress the innate inflammatory cytokine responses of human peripheral blood mononuclear cells challenged with lipopolysaccharide in vitro. Int. Immunopharmacol. 2011; 11: 939–947 http://dx.doi.org/10.1016/j.intimp.2011.02.006[Crossref]
• [17] Graves DT. Cytokines that promote periodontal tissue destruction. J Periodontol 2008;79:1585–91. http://dx.doi.org/10.1902/jop.2008.080183[WoS][Crossref]
• [18] Battino M, Greabu M, Totan A, Bullon P, Bucur A, Tovaru S et al. Oxidative stress markers in oral lichen planus. Biofact 2008;33:301–310 http://dx.doi.org/10.1002/biof.5520330406[Crossref]
• [19] Bajestan MN, Radvar M, Afshari JT, Naseh MR, Arab HR. Interleukin-6 production by cultured peripheral blood monocytes before and after stimulation by E. coli lipopolysaccharide in Iranian patients with aggressive periodontitis. Med Sci Monit 2006;12:CR393–396
• [20] Andrukhov O, Ulm C, Reischl H, Nguyen PQ, Matejka M, Rausch-Fan X. Serum cytokine levels in periodontitis patients in relation to the bacterial load. J Periodontol 2011;82:885–892 http://dx.doi.org/10.1902/jop.2010.100425[WoS][Crossref]
• [21] Zhu J, Paul WE. Peripheral CD4+ T-cell differentiation regulated by networks of cytokines and transcription factors. Immunol Rev 2010;238:247–262 http://dx.doi.org/10.1111/j.1600-065X.2010.00951.x[WoS][Crossref]
• [22] Nüsslein HG, Winter M, Träg T, Kalden JR. Interleukin-4-induced IgG subclass and IgE secretion by mononuclear cells from atopic donors. Int Arch Allergy Appl Immunol 1991;95:257–260 http://dx.doi.org/10.1159/000235438
• [23] Inagaki A, Ishida T, Ishii T, Komatsu H, Iida S, Ding J, Yonekura K, Takeuchi S, Takatsuka Y, Utsunomiya A, Ueda R. Clinical significance of serum Th1-, Th2- and regulatory T cells-associated cytokines in adult T-cell leukemia/lymphoma: high interleukin-5 and -10 levels are significant unfavorable prognostic factors. Int J Cancer 2006;15;118:3054–3061 http://dx.doi.org/10.1002/ijc.21688[Crossref]
• [24] Gamell E, Seymour GJ. Modulation of immune responses to periodontal bacteria. Curr Opin Periodontol. 1994;28–38
• [25] Kabashima H, Nagata K, Hashiguchi I, Toriya Y, Iijima T, Maki K et al.Interleukin-1 receptor antagonist and interleukin-4 in gingival crevicular fluid of patients with inflammatory periodontal disease.J Oral Pathol Med1996;25:449–455 http://dx.doi.org/10.1111/j.1600-0714.1996.tb00295.x
• [26] Pradeep AR, Roopa Y, Swati PP. Interleukin-4, a T-helper 2 cell cytokine, is associated with the remission of periodontal disease. J Periodontal Res 2008;43:712–716 http://dx.doi.org/10.1111/j.1600-0765.2007.01079.x[WoS][Crossref]
• [27] Rescala B, Rosalem W Jr, Teles RP, Fischer RG, Haffajee AD, Socransky SS, et al. Immunologic and microbiologic profiles of chronic and aggressive periodontitis subjects. J Periodontol 2010;81:1308–1316 http://dx.doi.org/10.1902/jop.2010.090643[Crossref][WoS]
• [28] Robati M, Ranjbari A, Boroujerdnia MG, Chinipardaz Z. Detection of IL-4, IL-6 and IL-12 Serum Levels in Generalized Aggressive Periodontitis. Iran J Immunol 2011;8:170–175
• [29] Te Velde AA, Huijbens RJF, Heije K, de Vries JE, Figdor CG. Interleukin-4 inhibits secretion of IL-1b, tumor necrosis factor-a and interleukin-6 by human monocytes. Blood 1990;76:1392–1397
• [30] Lappin DF, MacLeod CP, Kerr A, Mitchell T, Kinane DF. Anti-inflammatory cytokine IL-10 and T cell cytokine profile in periodontitis granulation tissue. Clin Exp Immunol 2001;123:294–300 http://dx.doi.org/10.1046/j.1365-2249.2001.01448.x[Crossref]
• [31] Tam V, O’Brien-Simpson NM, Chen YY, Sanderson CJ, Kinnear B, Reynolds EC.The RgpA-Kgp proteinaseadhesin complexes of Porphyromonas gingivalis inactivate the Th2 cytokines Interleukin-4 and Interleukin-5. Infect Immunol 2009;77:1451–1458 http://dx.doi.org/10.1128/IAI.01377-08
• [32] O’Brien-Simpson, N. M., R. D. Pathirana, G. Walker, and E. C. Reynolds. Porphyromonas gingivalis RgpA-Kgp proteinase-adhesin complexes penetrate gingival tissue and induce proinflammatory cytokines or apoptosis in a concentration-dependent manner. Infect Immun 2008; doi: 10.1128/IAI.01038-1008 [Crossref][WoS]
• [33] Sonck E, Stuyven E, Goddeeris B, Cox E. The effect of beta-glucans on porcine leukocytes. Vet Immunol Immunopathol 2010;135:199–207 http://dx.doi.org/10.1016/j.vetimm.2009.11.014[WoS][Crossref]
• [34] Niederman R, Kelderman H, Socransky S, Ostroff G, Genco C, Kent R, Jr, Stashenko P. Enhanced neutrophil emigration and Porphyromonas gingivalis reduction following PGG-glucan treatment of mice. Archiv Oral Biol 2002;47:613–618 http://dx.doi.org/10.1016/S0003-9969(02)00042-0[Crossref]

Identifiers

DOI

10.2478/s11536-012-0061-5